| Literature DB >> 28680706 |
Yuqun Zhang1,2, Yuan Yang3, Rongrong Bian1,2, Yingying Yin1,2, Zhenghua Hou1,2, Yingying Yue1,2, Zhi Xu1,2, Yonggui Yuan1,2.
Abstract
OBJECTIVE: To explore the underlying mechanism of depression in asthmatic patients, the ReHo in the insula and its FC was used to probe the differences between depressed asthmatic (DA) and nondepressed asthmatic (NDA) patients.Entities:
Mesh:
Year: 2017 PMID: 28680706 PMCID: PMC5478859 DOI: 10.1155/2017/7838035
Source DB: PubMed Journal: Neural Plast ISSN: 1687-5443 Impact factor: 3.599
Demographics and clinical characteristics of participants.
| DA ( | NDA ( | HCs ( |
| |
|---|---|---|---|---|
| Age (years) | 53.61 ± 9.08∗ | 50.58 ± 10.57 | 45.78 ± 14.49 | 0.051a |
| Gender (male/female) | 9/9 | 9/15 | 24/36 | 0.688b |
| Education (years) | 11.89 ± 2.56 | 11.75 ± 2.64 | 12.42 ± 3.57 | 0.639a |
| Duration of asthma (years) | 22.86 ± 20.19 | 21.42 ± 19.27 | — | 0.815c |
| HDRS-17 scores | 11.06 ± 4.40∗∗†† | 2.21 ± 1.47# | 0.93 ± 1.34 | <0.001a |
| ACT scores | 15.00 ± 4.38 | 19.58 ± 4.31 | — | 0.002c |
Note: data are expressed as mean ± standard deviation. aOne-way ANOVA; bChi-square test; cIndependent-sample t-test. DA versus HC, ∗P < 0.05, ∗∗P < 0.001; DA versus NDA, ††P < 0.001; NDA versus HC, #P < 0.05. DA: depressed asthma; NDA: nondepressed asthma; HCs: healthy controls; HDRS-17: 17-item Hamilton Depression Rating Scale; ACT: asthma control test.
The FC between vAI with the whole brain among DA, NDA, and HCs.
| Peak area | BA | Side | MNI coordinates | Voxels | Peak | ||
|---|---|---|---|---|---|---|---|
| X | Y | Z | |||||
|
| |||||||
|
| |||||||
| Cerebellum posterior lobe | — | L | −39 | −69 | −39 | 66 | 12.857 |
| Middle temporal gyrus | 21 | L | −51 | −21 | −6 | 77 | 10.0207 |
| ACC | 32 | B | 3 | 42 | 0 | 107 | 10.4837 |
| Parietal lobe | 7 | R | 15 | −66 | 51 | 161 | 20.4306 |
| Parietal lobe | 7 | L | −18 | −63 | 54 | 79 | 13.9602 |
|
| |||||||
| Cerebellum posterior lobe | — | L | −36 | −72 | −42 | 23 | −3.6785 |
| Middle temporal gyrus | 21 | L | −66 | −12 | −6 | 28 | 4.4333 |
| Parietal lobe | 7 | R | 15 | −66 | 51 | 52 | −4.8216 |
|
| |||||||
| Middle temporal gyrus | 20 | L | −39 | −12 | −6 | 77 | 4.4481 |
| ACC | 32 | B | −3 | 39 | 3 | 107 | 4.5744 |
| Parietal lobe | 7 | R | 15 | −66 | 51 | 161 | −6.2223 |
| Parietal lobe | 7 | L | −18 | −63 | 54 | 79 | −5.2783 |
|
| |||||||
| Cerebellum posterior lobe | — | L | −39 | −69 | −39 | 66 | 4.7411 |
| ACC | 32 | R | 6 | 36 | 6 | 62 | 3.862 |
| Parietal lobe | 7 | L | −18 | −63 | 48 | 20 | −3.2677 |
| Parietal lobe | 7 | R | 30 | −45 | 60 | 24 | −3.6245 |
|
| |||||||
|
| |||||||
|
| |||||||
| Putamen | — | L | −21 | 9 | 0 | 54 | 10.0985 |
| Caudate | — | R | 15 | 12 | 15 | 82 | 13.983 |
|
| |||||||
| Putamen | — | L | −21 | 15 | 0 | 7 | −3.2276 |
| Caudate | — | R | 15 | 12 | 18 | 12 | −3.55 |
|
| |||||||
| Putamen | — | L | −15 | 18 | 9 | 7 | 4.0056 |
| Caudate | — | R | 21 | 6 | 9 | 6 | 2.8772 |
|
| |||||||
| Putamen | — | L | −21 | 9 | 0 | 52 | 4.6445 |
| Caudate | — | R | 15 | 12 | 15 | 82 | 4.985 |
Note: ANCOVA threshold was set at P < 0.01/6 (AlphaSim-corrected, cluster size >1431 mm3). The independent t-test threshold was set at P < 0.01 (AlphaSim-corrected, cluster size >216 mm3 for left vAI and 135 mm3 for right vAI). X, Y, Z: coordinates of primary peak locations in the MNI space; MNI: Montreal Neurological Institute space; BA: Brodmann area; vAI: ventral anterior insula; L: left; R: right; B: bilateral; DA: depressed asthma; NDA: nondepressed asthma; HCs: healthy controls; ANCOVA: one-way analysis of covariance.
Figure 1Statistical maps showing vAI FC differences in different brain regions between the DA, NDA, and HC groups. ANCOVA significantly increased in vAI FC among the DA, NDA, and HCs groups (P < 0.01/6, AlphaSim corrected). The FC between left vAI with left cerebellum posterior lobe, left MTG, bilateral ACC, and bilateral parietal lobe were increased; the FC between right vAI with the left putamen and right caudate were also increased; the red color bar indicates the F value from ANCOVA among the three groups. DA-NDA significantly altered in vAI FC of DA patients compared with that of NDA patients (P < 0.01, AlphaSim corrected). DA patients showed increased left vAI FC with MTG, decreased left vAI FC with left cerebellum posterior lobe and right parietal lobe, and decreased right vAI FC with the left putamen and right caudate. DA-HC significantly changes in vAI FC of DA patients compared with that of HCs (P < 0.01, AlphaSim corrected). DA patients showed increased left vAI FC with left MTG and bilateral ACC, decreased left vAI FC with bilateral parietal lobe, and increased right vAI FC with the left putamen and right caudate. NDA-HC significantly altered in vAI FC of NDA patients compared with HCs (P < 0.01, AlphaSim corrected). The NDA patients showed increased left vAI FC with left cerebellum posterior lobe and right ACC, decreased left vAI FC with bilateral parietal lobe, and increased right vAI FC with the left putamen and right caudate. The color bar indicates the t value from independent samples t-test between the three groups. ANCOVA, analysis of covariance; DA, depressed asthma; NDA, nondepressed asthma; HCs, healthy controls; FC, functional connectivity; vAI, ventral anterior insula; MTG, middle temporal gyrus.
ROC analyses for separating different groups.
| Brain regions | AUC |
| 95% CI | Sensitivity | Specificity | Cut-off point |
|---|---|---|---|---|---|---|
|
| ||||||
|
| ||||||
| DA-NDA | 0.194 | 0.001 | 0.058–0.331 | 0.056 | 0.333 | −0.0095a |
| DA-HCs | 0.700 | 0.010 | 0.588–0.812 | 0.944 | 0.583 | −0.1290 |
| NDA-HCs | 0.820 | <0.001 | 0.720–0.920 | 0.917 | 0.683 | −0.0808 |
|
| ||||||
| DA-NDA | 0.759 | 0.004 | 0.606–0.912 | 0.778 | 0.708 | 0.0932 |
| DA-HCs | 0.831 | <0.001 | 0.709–0.952 | 0.778 | 0.833 | 0.0941 |
| NDA-HCs | 0.599 | 0.157 | 0.465–0.733 | 0.458 | 0.767 | 0.0632 |
|
| ||||||
| DA-NDA | 0.623 | 0.178 | 0.450–0.796 | 0.833 | 0.458 | 0.1389 |
| DA-HCs | 0.828 | <0.001 | 0.721–0.935 | 0.833 | 0.783 | 0.1450 |
| NDA-HCs | 0.709 | 0.003 | 0.586–0.833 | 0.542 | 0.800 | 0.1554 |
|
| ||||||
| DA-NDA | 0.257 | 0.008 | 0.102–0.412 | 0.278 | 0.292 | −0.1453 |
| DA-HCs | 0.129 | <0.001 | 0.024–0.233 | 0.222 | 0.083 | −0.1336 |
| NDA-HCs | 0.301 | 0.005 | 0.173–0.429 | 0.500 | 0.150 | −0.1057 |
|
| ||||||
| DA-NDA | 0.294 | 0.024 | 0.134–0.454 | 0.444 | 0.167 | −0.2058 |
| DA-HCs | 0.159 | <0.001 | 0.057–0.262 | 0.333 | 0.117 | −0.1446 |
| NDA-HCs | 0.314 | 0.008 | 0.189–0.438 | 0.542 | 0.117 | −0.1489 |
|
| ||||||
|
| ||||||
|
| ||||||
| DA-NDA | 0.336 | 0.071 | 0.170–0.502 | 0.111 | 0.542 | 0.3462 |
| DA-HCs | 0.644 | 0.066 | 0.510–0.777 | 0.778 | 0.550 | 0.2277 |
| NDA-HCs | 0.760 | <0.001 | 0.651–0.868 | 0.667 | 0.800 | 0.3013 |
|
| ||||||
| DA-NDA | 0.306 | 0.033 | 0.141–0.470 | 0.389 | 0.250 | 0.2506 |
| DA-HCs | 0.599 | 0.204 | 0.459–0.739 | 0.833 | 0.367 | 0.1431 |
| NDA-HCs | 0.778 | <0.001 | 0.677–0.880 | 0.875 | 0.617 | 0.2381 |
Note: aThis cut-off point resulted in a sensitivity of 5.6% and a specificity of 33.3% while DA patients separating from NDA patients. The means of other cut-off points were similar. ROC: receiver operating characteristic; AUC: area under the curve; CI: confidence interval; DA: depressed asthma; NDA: nondepressed asthma; HCs: healthy controls.
Figure 2ROC analyses. (a) ROC analyses differentiate DA from NDA patients by using FC values between left vAI with left cerebellum posterior lobe, left MTG, bilateral ACC, right parietal lobe, and left parietal lobe. The areas under the ROC curve for FC between left vAI with left cerebellum posterior lobe, left MTG, bilateral ACC, right parietal lobe, and left parietal lobe were 0.194 (P < 0.001; 95% CI: 0.058–0.331), 0.759 (P < 0.01; 95% CI: 0.060–0.912), 0.632 (P > 0.5; 95% CI: 0.450–0.796), 0.257 (P < 0.01; 95% CI: 0.102–0.412), and 0.294 (P < 0.05; 95% CI: 0.134–0.454), respectively. (b) ROC analyses differentiate DA from HC by using FC values between left vAI with left cerebellum posterior lobe, left MTG, bilateral ACC, right parietal lobe, and left parietal lobe. The areas under the ROC curve for FC between left vAI with left cerebellum posterior lobe, left MTG, bilateral ACC, right parietal lobe, and left parietal lobe were 0.700 (P < 0.01; 95% CI: 0.588–0.812), 0.831 (P < 0.001; 95% CI: 0.709–0.952), 0.828 (P < 0.001; 95% CI: 0.721–0.935), 0.129 (P < 0.001; 95% CI: 0.024–0.233), and 0.159 (P < 0.001; 95% CI: 0.057–0.262), respectively. (c) ROC analyses differentiate NDA from HC by using FC values between left vAI with left cerebellum posterior lobe, left MTG, bilateral ACC, right parietal lobe, and left parietal lobe. The areas under the ROC curve for FC between left vAI with left cerebellum posterior lobe, left MTG, bilateral ACC, right parietal lobe, and left parietal lobe were 0.820 (P < 0.001; 95% CI: 0.720–0.920), 0.599 (P > 0.5; 95% CI: 0.465–0.733), 0.709 (P < 0.01; 95% CI: 0.586–0.833), 0.301 (P < 0.01; 95% CI: 0.173–0.429), and 0.314 (P < 0.01; 95% CI: 0.189–0.438), respectively. (d) ROC analyses differentiate DA from NDA patients by using FC values between right vAI with the left putamen and right caudate. The areas under the ROC curve for FC between left vAI with the left putamen and right caudate were 0.336 (P > 0.05; 95% CI: 0.1700.502) and 0.306 (P < 0.05; 95% CI: 0.141–0.470), respectively. (e) ROC analyses differentiate DA patients from HC by using FC values between right vAI with the left putamen and right caudate. The areas under the ROC curve for FC between left vAI with the left putamen and right caudate were 0.644 (P > 0.05; 95% CI: 0.510–0.777) and 0.599 (P > 0.05; 95% CI: 0.459–0.739), respectively. (f) ROC analyses differentiate NDA patients from HC by using FC values between right vAI with the left putamen and right caudate. The areas under the ROC curve for FC between left vAI with left putamen and right caudate were 0.760 (P < 0.001; 95% CI: 0.651–0.868) and 0.778 (P < 0.001; 95% CI: 0.677–0.880), respectively. DA, depressed asthma; NDA, nondepressed asthma; HC, healthy controls; ACC, anterior cingulate cortex; FC, functional connectivity; vAI, ventral anterior insula; MTG, middle temporal gyrus.